01 1Taro Pharmaceutical Industries
01 1ADAPALENE USP, MICRONIZED
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-07
Pay. Date : 2014-03-11
DMF Number : 21208
Submission : 2008-01-02
Status : Active
Type : II
20
Taro Pharmaceutical Industries Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ADAPALENE USP, MICRONIZED, with a corresponding US DMF Number 21208.
Remarkably, this DMF maintains an Active status since its submission on January 02, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 07, 2014, and payment made on March 11, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
